Amd3100 Administration For The Treatment Of Asherman’s Syndrome In A Murine Model

Author

Pablo Antonio DelisFollow

Date of Award

January 2022

Document Type

Open Access Thesis

Degree Name

Medical Doctor (MD)

Department

Medicine

First Advisor

Valerie A. Flores

Abstract

Statement of Purpose

1. Optimize a murine model of Asherman’s Syndrome.2. Assess fertility outcomes in mild Asherman’s Syndrome model mice treated with AMD3100. 3. Determine timing of peak serum and uterine levels of CXCL12 after AS induction. 4. Identify an optimal time point for AMD3100 administration in AS.

Comments

This is an Open Access Thesis.

Recommended Citation

Delis, Pablo Antonio, "Amd3100 Administration For The Treatment Of Asherman’s Syndrome In A Murine Model" (2022). Yale Medicine Thesis Digital Library. 4064.
https://elischolar.library.yale.edu/ymtdl/4064